Friday 6 November 2026
Export VSEE’s income statement to Excel — free account
VSee Health, Inc.
VSEE Healthcare Health Information Services
VSee Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.6 million, up 40.3% from fiscal 2024.
- Revenue
- −53.9%
- EPS
- +109.9%
- Free cash flow
- −257.6%
- Total debt
- +31.6%
Quarter to June 2026, against a year earlier
1.15
0.00
0.00%
Follow VSEE
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | — | 4 | 4 |
| 2,466.75% | (541.52%) | (945.70%) | (1,065.78%) | ||
| (46.05%) | (69.39%) | (69.53%) | (56.62%) | ||
ROIC |
0.00% | (602.00%) | (116.45%) | (93.65%) | |
Return on Tangible Assets |
52.22% | 193.99% | 199.66% | 209.77% | |
Average Days of Receivables |
65.24 | 55.96 | 67.44 | 64.48 | |
Free Cash Flow per Share |
(21.93) | (13.86) | (9.21) | (9.40) | |
Free Cash Flow |
(4.54) | (3.49) | (5.52) | (6.31) | |
Capital Expenditures |
(0.04) | (0.05) | (0.06) | — | |
| Other line items | |||||
Cash ROIC |
100.53% | (31.46%) | (65.31%) | (71.43%) | |
Accounts Receivable Turnover |
5.56 | 7.39 | 6.39 | 6.56 | |
Accounts Payable Turnover |
0.52 | 0.78 | 0.86 | 1.08 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
828.44 | 468.95 | 401.06 | 269.01 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.22 | 0.00 | (0.01) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
106.19% | 115.87% | 120.50% | 143.74% | |
Share Based Compensation of Revenue |
8.02% | 7.69% | 8.12% | 7.95% | |
Interest Coverage |
(5.83) | (3.41) | (4.89) | (5.78) | |
Operating CF/Net income |
0.45 | 0.23 | 0.41 | 0.64 | |
Depreciation/Fixed assets |
6.48 | 9.00 | 9.94 | 23.09 | |
Capex/Depreciation |
(0.02) | (0.02) | (0.02) | 0.00 | |
Revenue per Share |
69.73 | 58.06 | 24.14 | 18.83 | |
Operating CF per Share |
(21.72) | (13.68) | (9.11) | (9.40) | |
Capex per Share |
(0.21) | (0.18) | (0.10) | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026